Severe acute respiratory syndrome

EPA-Approved Antimicrobial Surface Coating Represents Breakthrough In The Control And Spread Of Infectious Diseases

Retrieved on: 
Thursday, March 19, 2020

"This product represents a breakthrough in killing microbes responsible for a number of infectious diseases, including potentially SARS-CoV-2, the virus responsible for the COVID-19, pandemic," said Bryan Glynson, Chief Executive Officer of Alistagen.

Key Points: 
  • "This product represents a breakthrough in killing microbes responsible for a number of infectious diseases, including potentially SARS-CoV-2, the virus responsible for the COVID-19, pandemic," said Bryan Glynson, Chief Executive Officer of Alistagen.
  • "The technology behind this product application represents a whole new category of infectious disease control.
  • Painting or otherwise coating an area with Caliwel BNA decontaminates the area.
  • Further, painting a surface with Caliwel BNA calcium hydroxide-based coating seals off any pathogenic organism on the painted surface in the unlikely event that it is not been entirely killed by the calcium hydroxide in the coating."

AACC Launches Directory of U.S. Labs That Are Performing COVID-19 Testing

Retrieved on: 
Thursday, March 19, 2020

This directory is designed to help healthcare providers quickly find laboratories that can diagnose patients suspected to have COVID-19.

Key Points: 
  • This directory is designed to help healthcare providers quickly find laboratories that can diagnose patients suspected to have COVID-19.
  • To help providers facing this dilemma, AACCa medical professional organization dedicated to better health through laboratory medicinehas created the AACC COVID-19 Testing Directory .
  • This directory currently contains the contact information for 40 labs located in 25 states across the country that are, or will soon be, performing and accepting orders for SARS-CoV-2 testing.
  • "AACC developed the COVID-19 Testing Directory to connect these labs with the many healthcare providers who are looking for coronavirus testing.

Pandemic Concerns Rattle U.S. Travelers, but Nearly Half Plan to Travel in the Next Six Months: Omnitrak

Retrieved on: 
Thursday, March 19, 2020

More than a quarter, or 29 percent, have cancelled leisure travel and 12 percent have cancelled business travel since January 2020.

Key Points: 
  • More than a quarter, or 29 percent, have cancelled leisure travel and 12 percent have cancelled business travel since January 2020.
  • During recent disease outbreaks, natural disasters and world events, including post-9/11, SARS, Ebola and plane crashes, travelers have remained resilient.
  • During recent disease outbreaks, including SARS and Ebola, 83 percent of U.S. travelers did not change their travel plans.
  • Travel advice from national political leaders is relatively low at 29 percent, on par with information from local news media.

Orion Biotechnology to Present at the BIO-Europe Spring 2020 Virtual Event

Retrieved on: 
Thursday, March 19, 2020

Ottawa, Canada, March 19, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company , today announced that it will be presenting an update on the companys development program at the BIO-Europe Spring 2020 meeting, originally planned to be held in Paris, France.

Key Points: 
  • Ottawa, Canada, March 19, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company , today announced that it will be presenting an update on the companys development program at the BIO-Europe Spring 2020 meeting, originally planned to be held in Paris, France.
  • Due to the SARS-CoV-2 pandemic, the presentation will be part of a virtual event.
  • The presentation will be given by Dr. Ian McGowan who is the Chief Medical Officer at Orion Biotechnology.
  • Mark Groper, President and CEO of Orion Biotechnology said 2020 is shaping up to be a very busy year for Orion Biotechnology.

TOMI’S EXCLUSIVE PARTNER CLEAN-BIT EXPANDS STERAMIST THROUGHOUT ISRAEL

Retrieved on: 
Thursday, March 19, 2020

TOMIs exclusive partner in Israel, Clean-Bit, expands their SteraMist disinfection services.

Key Points: 
  • TOMIs exclusive partner in Israel, Clean-Bit, expands their SteraMist disinfection services.
  • TOMI entered into an exclusive agreement with Clean-Bit for use of SteraMist throughout Israel.
  • Clean-Bit has bought over 1.6 million dollars to date of TOMI technology and Solution for use in Israel.
  • Yaki Agam, CEO of Clean-Bit, TOMIs partner in Israel, says Clean-Bit has developed its own 'virus fighting bible' and is preventing the spread of the SARS CoV-2 coronavirus throughout the entire state of Israel.

Antech aligns with global health organizations on COVID-19 in cats and dogs: No virus detected

Retrieved on: 
Thursday, March 19, 2020

Antech's active surveillance program is intended to detect any possible emergence of the virus among companion animals.

Key Points: 
  • Antech's active surveillance program is intended to detect any possible emergence of the virus among companion animals.
  • Antech's surveillance program involves testing samples from dogs and cats that are submitted for respiratory PCR analysis.
  • Antech is validating samples to ensure there is no evidence of the SARS-CoV-2 virus in the companion animals tested.
  • Today, Antech is driving the future of pet health as part of Mars Veterinary Health, a family-owned company focused on veterinary care.

Avellino Expands Production of Genetic Test Kits for Coronavirus Detection

Retrieved on: 
Thursday, March 19, 2020

Avellino announced today that it is adding additional production shifts for its newly developed coronavirus diagnostic, the Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2, for short).

Key Points: 
  • Avellino announced today that it is adding additional production shifts for its newly developed coronavirus diagnostic, the Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2, for short).
  • Avellino Group Chairman Gene Lee said, We appreciate the support from eye care professionals who are now using the AvaGen genetic test to care for their corneal patients.
  • Avellino will restart production of the AvaGen genetic test as soon as we have fulfilled our public health obligation surrounding the coronavirus pandemic.
  • Therefore, a genetic test such as the AvellinoCoV2 test provides clinicians and public health officials with a valuable diagnostic tool.

QIAGEN launches QIAstat-Dx test kit for detection of SARS-CoV-2 coronavirus in Europe following CE marking

Retrieved on: 
Wednesday, March 18, 2020

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has obtained CE marking for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test to be sold as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2.

Key Points: 
  • QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has obtained CE marking for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test to be sold as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2.
  • The QIAstat-Dx Respiratory SARS-CoV-2 Panel is a multiplexed nucleic acid test that evaluates samples such as nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections.
  • The newly approved panel includes assays targeting two genes used to detect the pathogen behind the disease, Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2).
  • We are pleased to launch the QIAstat-Dx SARS-CoV-2 test kits in Europe for clinical laboratories.

CharmHealth, MedicalMine Inc.'s Cloud-Based Platform, Launches Tools and Promotions to Help Healthcare Providers Manage COVID-19

Retrieved on: 
Wednesday, March 18, 2020

The World Health Organization on Wednesday declared the rapidly spreading coronavirus outbreak, associated with the transmission of the novel coronavirus (SARS-CoV-2) a pandemic.

Key Points: 
  • The World Health Organization on Wednesday declared the rapidly spreading coronavirus outbreak, associated with the transmission of the novel coronavirus (SARS-CoV-2) a pandemic.
  • This should help providers treat patients remotely and securely while containing the spread of the infection at hospitals, clinics and medical offices.
  • "As the world is grappling with the rising toll of the COVID-19 pandemic, healthcare workers are at the front-line managing this crisis.
  • By launching these CDC-recommended resources at their finger-tips, we hope that we can mitigate the difficulties faced by healthcare providers at this time of emergency.

Q.A. Solution by National Chemicals Authorized for COVID-19 Disinfection

Retrieved on: 
Wednesday, March 18, 2020

Concentrated Solution from National Chemicals, Inc (NCI) has demonstrated effectiveness against viruses similar to SARS-CoV-2 virus (COVID-19) on hard, non-porous surfaces.

Key Points: 
  • Concentrated Solution from National Chemicals, Inc (NCI) has demonstrated effectiveness against viruses similar to SARS-CoV-2 virus (COVID-19) on hard, non-porous surfaces.
  • Concentrated Solution will be made available to the public and wholesale buyers on the National Chemicals' company website.
  • Concentrated Solution is easy to use, and each bottle produces large quantities of proven disinfecting solution for a wide range of cleaning and anti-microbial applications.
  • **
    To accommodate every customer, and ensure orders are processed quickly and fairly, all transactions for Q.A Concentrated Solution must occur on the National Chemicals website at www.nationalchemicals.com .